1.
Karaman O, Kim M, Scurti G, Kraśko JA, Bochnacka O, Quinn S, et al. CD19 Chimeric Antigen Receptor (CAR) modified cytokine killer cells compared to classical CD19 CAR-T: advantages and disadvantages. SEE J Immunol [Internet]. 2025 Mar. 25 [cited 2026 Nov. 17];8(CITIM):062. Available from: https://seejim.eu/index.php/seejim/article/view/6123